 |
Pegaspargase |
|---|---|
| Trade Name | Oncaspar |
| Orphan Indication | Acute lymphoblastic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1989-10-20 00:00:00 |
| Sponsor | Baxalta US, Inc.;650 Kendall Street;Cambridge, Massachusetts, 02142 |
Related Access Program
Novartis Pharmaceuticals – Acute Lymphoblastic Leukemia
University of California, San Francisco – Acute Lymphoblastic Leukemia
ERYtech Pharma – Acute Lymphoblastic Leukemia
University of California, San Francisco – Acute lymphoblastic leukemia
ERYtech Pharma – Acute lymphoblastic leukemia
Amgen – Acute lymphoblastic leukemia